… The emergence of SARS-CoV-2 variants requires an expanded research agenda to improve
our understanding of emerging SARS-CoV-2 mutations and the correlates of protective …

… A subset of T cells primed against seasonal coronaviruses cross reacts with SARS-CoV-2
and may contribute to clinical protection, particularly in early life. T cell memory encompasses …

… infections by SARS-CoV, MERS-CoV and SARS-CoV-2 may … SARS-CoV-2 samples
against several viruses circulating in animals being suspected as likely progenitors of SARS-CoV…

… to protection. This is an important piece of the puzzle since the protective titre for SARS-CoV-…
titres as a correlate of protection and defining a protective titre would be extremely important …

… are considered equally protected as … , clinicians should remain optimistic regarding the
protective effect of recovery from previous infection. Community immunity to control the SARS-CoV…

… intranasal SARS-CoV-2 infection in hamsters results in severe clinical … SARS-CoV-2 spike
protein elicited binding and neutralizing antibody responses and protected against SARS-CoV…

… against initial infection, and perhaps transmission, but protection against severe disease is
maintained. Clinical trials of SARS-CoV-2 vaccines have consistently shown higher efficacy …

… preclinical and clinical data on SARS-CoV-2 vaccines that are currently in Phase III clinical
trials … We further discuss relevant vaccine platforms and provide a discussion of SARS-CoV-2 …

… This review points out the current knowledge on the role of NAbs in the protection of
SARS-CoV-2 infection and their potential clinical implications in COVID-19, as well as summarizes …

… and clinical protection to understand the loss of neutralisation to existing SARS-CoV-2 variants
… model relating in-vitro neutralisation to protection (parameterised on data from ancestral …